The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity
Cell · 2024-12 · 187 (25) · 7183-7195.e24
DOI: 10.1016/j.cell.2024.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-12. Verfasst von Christian F Baca und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bacteriology, The Rockefeller University, New York, NY 10065, USA; Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Med…. Hauptthemen laut MEDLINE: Adenosine Deaminase, Adenosine Triphosphate, CRISPR-Cas Systems. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Bacteriology, The Rockefeller University, New York, NY 10065, USA; Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Canc…
- Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
- Laboratory of Bacteriology, The Rockefeller University, New York, NY 10065, USA.
- Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Laboratory of Genetically Encoded Small Molec…
- Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, NY 10065, USA.
- Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Electronic address: pateld@mskcc.org.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
Zitieren
APA
Baca, C. F., Majumder, P., Hickling, J. H., Ye, L., Teplova, M., Brady, S. F., Patel, D. J., & Marraffini, L. A. (2024). The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity. Cell, 187(25), 7183-7195.e24. https://doi.org/10.1016/j.cell.2024.10.002
Vancouver
Baca CF, Majumder P, Hickling JH, Ye L, Teplova M, Brady SF, et al. The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity. Cell. 2024;187(25):7183-7195.e24. doi:10.1016/j.cell.2024.10.002
BibTeX
@article{Baca2024,
author = {Baca, Christian F and Majumder, Puja and Hickling, James H and Ye, Linzhi and Teplova, Marianna and Brady, Sean F and Patel, Dinshaw J and Marraffini, Luciano A},
title = {The CRISPR-associated adenosine deaminase Cad1 converts ATP to ITP to provide antiviral immunity},
journal = {Cell},
year = {2024},
volume = {187},
number = {25},
pages = {7183--7195.e24},
doi = {10.1016/j.cell.2024.10.002}
}
EUVIMED